Demegel

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameDemegel
Drug Alias NameProvenaD2A21 gel - DemegenPeptidyl MIMD2A21
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell membrane modulatorsApoptosis stimulants
TargetsNot applicable
Therapy Area/IndicationsBurnsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesDemegenDfb Pharmaceuticals
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsBurnsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A